Intravenous antihypertensive drugs: a double-edged sword?
J Hypertens
.
2023 Feb 1;41(2):220-222.
doi: 10.1097/HJH.0000000000003344.
Authors
Daan J L van Twist
1
,
Bas L J H Kietselaer
2
Affiliations
1
Department of Internal Medicine, Zuyderland Medical Centre, Sittard/Heerlen, The Netherlands.
2
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
PMID:
36583349
DOI:
10.1097/HJH.0000000000003344
No abstract available
Publication types
Editorial
Comment
MeSH terms
Administration, Intravenous
Antihypertensive Agents* / adverse effects
Humans
Substances
Antihypertensive Agents